{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:58:23Z","timestamp":1760608703919},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.niox.2012.07.001","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T09:39:00Z","timestamp":1342777140000},"page":"185-191","source":"Crossref","is-referenced-by-count":14,"title":["Localization and expression of inducible nitric oxide synthase in patients after BCG treatment for bladder cancer"],"prefix":"10.1016","volume":"27","author":[{"given":"Lotta Renstr\u00f6m","family":"Koskela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"Poljakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Ehr\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Peter","family":"Wiklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra J.","family":"de Verdier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2012.07.001_b0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.niox.2012.07.001_b0010","first-page":"147","article-title":"Natural history of carcinoma in situ of the urinary bladder","volume":"157","author":"Wolf","year":"1994","journal-title":"Scand. J. Urol. Nephrol. Suppl."},{"key":"10.1016\/j.niox.2012.07.001_b0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2009.11.023","article-title":"The role of bacillus Calmette-Guerin in the treatment of non-muscle-invasive bladder cancer","volume":"57","author":"Gontero","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.niox.2012.07.001_b0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J. Urol."},{"key":"10.1016\/j.niox.2012.07.001_b0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-5347(17)43909-7","article-title":"Requirement of a thymus dependent immune response for BCG-mediated antitumor activity","volume":"137","author":"Ratliff","year":"1987","journal-title":"J. Urol."},{"key":"10.1016\/j.niox.2012.07.001_b0030","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.4049\/jimmunol.147.8.2802","article-title":"Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro","volume":"147","author":"Klostergaard","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.niox.2012.07.001_b0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/1043-4666(90)90013-J","article-title":"Detection of urinary TNF, IL 1, and IL 2 after local BCG immunotherapy for bladder carcinoma","volume":"2","author":"Bohle","year":"1990","journal-title":"Cytokine"},{"key":"10.1016\/j.niox.2012.07.001_b0040","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0022-5347(17)39713-6","article-title":"Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy","volume":"144","author":"Prescott","year":"1990","journal-title":"J. Urol."},{"key":"10.1016\/j.niox.2012.07.001_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/1367-8280(94)90083-3","article-title":"NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines","volume":"108","author":"Oswald","year":"1994","journal-title":"Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol."},{"key":"10.1016\/j.niox.2012.07.001_b0050","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4049\/jimmunol.138.2.550","article-title":"l-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells","volume":"138","author":"Hibbs","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.niox.2012.07.001_b0055","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0090-4295(96)00423-2","article-title":"Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis","volume":"48","author":"Lundberg","year":"1996","journal-title":"Urology"},{"issue":"Pt 2","key":"10.1016\/j.niox.2012.07.001_b0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2980249","article-title":"Nitric oxide synthases in mammals","volume":"298","author":"Knowles","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.niox.2012.07.001_b0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0090-4295(99)00120-X","article-title":"Measurement of luminal nitric oxide in bladder inflammation using a silicon balloon catheter: a novel minimally invasive method","volume":"54","author":"Ehren","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.niox.2012.07.001_b0070","unstructured":"http:\/\/www.gene-quantification.de\/pfaffl-rel-quan-book-ch3.pdf."},{"key":"10.1016\/j.niox.2012.07.001_b0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00299720","article-title":"Cytostatic effect of different strains of Bacillus Calmette-Guerin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-alpha","volume":"20","author":"Rajala","year":"1992","journal-title":"Urol. Res."},{"key":"10.1016\/j.niox.2012.07.001_b0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.biopha.2007.05.004","article-title":"Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement","volume":"61","author":"Brandau","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.niox.2012.07.001_b0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.niox.2006.01.007","article-title":"Enhanced formation of nitric oxide in bladder carcinoma in situ and in BCG treated bladder cancer","volume":"15","author":"Hosseini","year":"2006","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2012.07.001_b0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.niox.2005.04.012","article-title":"The effect of intravesical Bacillus Calmette-Guerin instillations on the expression of inducible nitric oxide synthase in humans","volume":"13","author":"Mitropoulos","year":"2005","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2012.07.001_b0095","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00005392-200102000-00093","article-title":"Bacillus Calmette-Guerin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells","volume":"165","author":"Morcos","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.niox.2012.07.001_b0100","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1073\/pnas.92.10.4392","article-title":"Roles of nitric oxide in tumor growth","volume":"92","author":"Jenkins","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.niox.2012.07.001_b0105","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.1073\/pnas.91.20.9407","article-title":"Nitric oxide is an important mediator for tumoricidal activity in vivo","volume":"91","author":"Farias-Eisner","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.niox.2012.07.001_b0110","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0090-4295(99)00033-3","article-title":"Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines","volume":"53","author":"Morcos","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.niox.2012.07.001_b0115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/bjc.1998.545","article-title":"The role of nitric oxide in bacillus Calmette-Guerin mediated anti-tumour effects in human bladder cancer","volume":"78","author":"Jansson","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.niox.2012.07.001_b0120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/cimm.2000.1682","article-title":"Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells","volume":"203","author":"Kwak","year":"2000","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.niox.2012.07.001_b0125","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1021\/tx00030a017","article-title":"Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide","volume":"5","author":"Koppenol","year":"1992","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.niox.2012.07.001_b0130","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0006-291X(84)90288-2","article-title":"Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages","volume":"123","author":"Hibbs","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2012.07.001_b0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-291X(88)80015-9","article-title":"Nitric oxide: a cytotoxic activated macrophage effector molecule","volume":"157","author":"Hibbs","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2012.07.001_b0140","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.4049\/jimmunol.146.6.1928","article-title":"Effect of l-arginine on the retention of macrophage tumoricidal activity","volume":"146","author":"Takema","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.niox.2012.07.001_b0145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1006\/bbrc.1996.1816","article-title":"Cytokine and low-level nitric oxide prestimulation block p53 accumulation and apoptosis of RAW 264.7 macrophages","volume":"229","author":"Brune","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2012.07.001_b0150","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-5347(01)61985-2","article-title":"Inducible nitric oxide synthase with transitional cell carcinoma of the bladder","volume":"161","author":"Swana","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.niox.2012.07.001_b0155","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0090-4295(99)00212-5","article-title":"Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer","volume":"54","author":"Klotz","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.niox.2012.07.001_b0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.niox.2004.11.003","article-title":"Expression of inducible nitric oxide synthase in tumoral and non-tumoral epithelia from bladder cancer patients","volume":"12","author":"Sandes","year":"2005","journal-title":"Nitric Oxide"},{"issue":"Suppl 1","key":"10.1016\/j.niox.2012.07.001_b0165","first-page":"1","article-title":"BCG\u2019s mechanism of action - increasing our understanding. For the EBIN Group.","volume":"37","author":"Bohle","year":"2000","journal-title":"Eur. Urol."},{"key":"10.1016\/j.niox.2012.07.001_b0170","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0022-5347(05)66410-5","article-title":"The fate of bacillus Calmette-Guerin after intravesical instillation","volume":"165","author":"Durek","year":"2001","journal-title":"J. Urol."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860312002832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860312002832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T14:43:38Z","timestamp":1687617818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860312002832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1089860312002832"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2012.07.001","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}